A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Experts fear a resurgence of infections in low-income countries if the ban were to continue. The waiver remains in place, ...

With the exception of EPI-Pens, participants who need to take medication while attending the a CU Boulder Youth Program must either self-administer the medication or work with the CU Boulder Center ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had ...

On Sunday night, the Trump administration told organizations that receive U.S. aid under PEPFAR to stop distributing HIV ...

An Australian influencer who allegedly 'tortured' her 1-year-old daughter by making her sick amid a scam to get donations and ...

The Food and Drug Administration on Tuesday approved Journavx, the first drug in a new class of non-opioid pain medications, ...

Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration ...

Secretary of State Marco Rubio announced the waiver on Tuesday; however, exactly what it covers remains unclear. While the waiver does allow for the resumption of distributing HIV medications, the ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...